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Obesity, defined as an excessive increase in white adipose tissue (WAT), is a global health epidemic. In
obesity, WAT expands by increased adipocyte size (hypertrophy) and number (hyperplasia). The location
and cellular mechanisms of WAT expansion greatly affect the pathogenesis of obesity. However, the cellular
and molecular mechanisms regulating adipocyte size, number, and depot-dependent expansion in vivo
remain largely unknown. This perspective summarizes previous work addressing adipocyte number in devel-
opment and obesity and discusses recent advances in the methodologies, genetic tools, and characteriza-
tion of in vivo adipocyte precursor cells allowing for directed study of hyperplastic WAT growth in vivo.Introduction
White adipose tissue (WAT) is a highly plastic and dynamic tis-
sue, accounting for less than 5% of body weight in some individ-
uals to over 60% in others, with an exceptional ability to change
in mass even within individuals (Drøyvold et al., 2006; Guo et al.,
1999). Excessive accumulation of WAT is the defining feature of
obesity, which is clinically defined as a body mass index (BMI =
kg/m2) exceeding 30 (WHO, 2013). Over the last three decades,
the prevalence of obesity has risen dramatically throughout the
world, and nowmore than 35%of adults within the US are obese
(Ogden et al., 2012; WHO, 2013). This worldwide increase in
adiposity has become a major public health concern, as obesity
is a risk factor for several pathologies, including type 2 diabetes,
cardiovascular disease, and some forms of cancer (WHO, 2013).
For these and other reasons, the American Medical Association
has recently classified obesity as a disease, further highlighting
the importance of understanding WAT mass regulation in vivo.
The development of obesity has largely been attributed to
overconsumption of food and decreased physical activity, as
chronic positive energy balance results in the expansion of
WAT due to the storage of excess energy as triglycerides within
WAT (Spiegelman and Flier, 2001). It is well appreciated that
regulation of food intake and energy expenditure is controlled
by neuronal signaling within the hypothalamus, and dysregula-
tion of this signaling leads to energy imbalance and obesity
(Friedman, 2004; Sternson et al., 2013). However, the WAT-
intrinsic mechanisms that lead to the increase in tissue mass in
response to positive energy imbalance are unknown. Even in
cases of extreme positive energy balance, such as themassively
obese leptin-deficient ob/ob mouse, there must be molecular
processes active within WAT that regulate tissue expansion.
Expansion of WAT occurs through both increased lipid filling
within existing mature adipocytes to increase adipocyte size
(hypertrophic WAT growth) and increased differentiation of
adipocyte precursor cells to increase adipocyte number (hyper-
plastic WAT growth; also referred to as adipogenesis) (Joe et al.,
2009; Wang et al., 2013). While genetics and obesogenic stimuli
can affect the relative contribution of these mechanisms to the
total accumulation of WAT in obesity (Jo et al., 2009), the8 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.WAT-intrinsic mechanisms involved in regulating adipocyte
size and number in vivo are largely unknown.
The location ofWAT accumulation can affect the pathogenesis
of obesity. Specifically, WAT accumulates throughout the body
in several distinct subcutaneous (SWAT) and visceral (VWAT)
depots (Cinti, 2005). In humans, the accumulation of VWAT
and deep abdominal SWAT correlates with increased risk of dia-
betes, cardiovascular disease, and mortality (Carey et al., 1997;
Goodpaster et al., 1997; Kelley et al., 2000; Nicklas et al., 2006;
Wang et al., 2005). Conversely, the accumulation of gluteofe-
moral SWAT, which is more prevalent in females, is associated
with insulin sensitivity and decreased risk of diabetes and cardio-
vascular disease (Manolopoulos et al., 2010; Misra et al., 1997;
Snijder et al., 2003; Tanko´ et al., 2003). In rodents, inguinal (pos-
terior) SWAT is associated with improved metabolic parameters
(Tran et al., 2008), similar to human gluteofemoral SWAT, while
mouse perigonadal VWAT is associated with decreased insulin
sensitivity (Foster et al., 2010). Therefore, determining how
WAT accumulation affects metabolic disease requires under-
standing howWATmass is regulated at specific anatomical sites
in vivo.
Recent advances in the identification and isolation of in vivo
adipocyte precursor cells now allows for directed study of the
cellular andmolecular mechanisms regulating adipocyte number
in both development and obesity (Lee et al., 2012; Rodeheffer
et al., 2008; Tang et al., 2008). Here, we detail the current knowl-
edge of adipocyte precursor cells, including their developmental
lineage, tissue localization, and abundance within WAT depots.
We will also summarize previous work on the contribution of
adipocyte number to the development and obesogenic expan-
sion of WAT. Finally, we will discuss common approaches
used to study these cells in vitro and in vivo, with a specific focus
on genetic models useful for labeling and manipulating the
adipocyte cellular lineage in vivo.
Establishment of Adipocyte Number during
Development
It is established that WAT forms early in life, initially arising from
highly vascularized primitive organs that are observed at sites of
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et al., 2011; Wassermann, 1927, 1929). In humans, lipid filling of
adipocyte precursors is first visible in loose connective tissue
structures called fat lobules during the second trimester (starting
at 14 weeks) (Poissonnet et al., 1983). These primitive adipose
tissue depots progressively increase in both size and number
until gestational week 23, when fat lobule number begins to
plateau. In the followingweeks, fat lobule growth is almost exclu-
sively accomplished through hypertrophy of existing adipocytes
(Berg, 1911; Poissonnet et al., 1983, 1984). Postnatally, the
SWAT depot in nonobese children remains relatively quiescent
until 10 years of age, when adipocyte number increases again
through the teenage years before plateauing at the end of
adolescence (Knittle, 1978; Knittle et al., 1979; Spalding et al.,
2008). Less is known about the timing of VWAT establishment
in humans, but there is little VWAT mass in nonobese individuals
prior to puberty (Fox et al., 1993; Siegel et al., 2007), and at least
some WAT within the abdominal cavity does not form until after
birth (Wassermann, 1927).
In mice, SWAT primitive organs become populated by cells
expressing adipogenic markers relatively late in embryogenesis,
with overt lipid filling of white adipocytes being initiated at birth
(Birsoy et al., 2011). The visceral perigonadal WAT (GWAT) depot
forms after birth, with determined adipocyte precursors first
appearing at postnatal day 4 (P4) and lipid accumulation in
developing GWAT evident at P7 (Han et al., 2011). The relative
contribution of adipocyte size and number to murine WAT devel-
opment is not well characterized, but studies in rats show in-
creases in both adipocyte number and size early in life, followed
by a plateau in adipocyte number by 3 months of age, with WAT
mass increases thereafter resulting from increased adipocyte
size (Greenwood and Hirsch, 1974; Hirsch and Han, 1969; John-
son et al., 1971). A recent study using inducible, indelible labeling
specifically in mature adipocytes via the adiponectin promoter
(termed AdipoChaser mice) supports these findings, showing
that the vast majority of mature adipocytes in mouse SWAT
are formed prenatally. Conversely, VWAT adipocytes are formed
during the first few weeks of life, with little formation of new
adipocytes in early adulthood (Wang et al., 2013). Similar cellular
mechanisms of WAT mass establishment have been reported in
birds, ruminants, and fish (Anderson and Kauffman, 1973; Flynn
et al., 2009; Hood and Allen, 1973; Imrie and Sadler, 2010; Pfaff
and Austic, 1976). This collection of studies indicates that there
is an overarching framework of WAT development in which WAT
depots are initially formed, both embryonically and postnatally,
through a combination of hyperplastic and hypertrophic mecha-
nisms that culminate in the stabilization of adipocyte number by
the end of adolescence (Greenwood et al., 1979; Greenwood
and Hirsch, 1974; Knittle and Hirsch, 1968) and the stabilization
of adipocyte size in early adulthood (Hemmeryckx et al., 2010;
Ha¨ger et al., 1977; Stiles et al., 1975).
In nonobese conditions, adipocyte number remains relatively
constant in adult animals (Stiles et al., 1975), even during starva-
tion and refeeding (Hirsch and Han, 1969; Yang et al., 1990),
suggesting that the plateau in adipocyte number at the end of
adolescence establishes an adipocyte number set point in
some conditions. In support of this idea, excision of inguinal
SWAT from rats prior to the end of adolescence results in
compensation by the remaining SWAT to generate the sametotal number of SWAT adipocytes as control animals (Faust
et al., 1977a), a response not observed when WAT is excised
from adult animals (Faust et al., 1977b; Kral, 1976). Additionally,
indirect dietary manipulation through modulation of litter size
during early development can lead to long-lasting decreases in
adipocyte number (Knittle and Hirsch, 1968). These findings
support that there is a critical developmental period for the
establishment of adipocyte number and that there is an adipo-
cyte number set point under normal conditions. Thus, increased
adipocyte number generated during adolescence may enhance
the capacity to store lipid in adult life (Spalding et al., 2008). Addi-
tionally, it was recently shown that mature adipocytes turn over
at a constant, albeit slow, rate in adulthood (Spalding et al.,
2008; Wang et al., 2013), indicating that maintenance of the
adipocyte number normally involves a tightly regulated balance
of adipogenesis and adipocyte death. The mechanisms involved
in the maintenance of adipocyte number throughout life are not
known, but in obesity this balance can be at least temporarily
disturbed, leading to adipocyte hyperplasia in many models of
obesity.
Regulation of Adipocyte Number in Obesity
While adipocyte hypertrophy is a common feature of obesity,
studies have shown varying contributions of increased adipo-
cyte number to obesogenic increases in WAT mass. Some early
studies in rodents and humans showed no increase in adipocyte
number in obesity, indicating that the observedWATmass accu-
mulation was solely due to adipocyte hypertrophy (Hirsch and
Han, 1969; Hirsch and Knittle, 1970; Johnson and Hirsch,
1972; Salans et al., 1973). Given the upper limit on adipocyte
size (Clara, 1927b; Leonhardt et al., 1972), expansion by hyper-
trophy alone would limit WAT gain. Therefore, in order to achieve
the WAT mass increase seen in cases of extreme (morbid)
obesity, increased adipocyte number must accompany adipo-
cyte hypertrophy.
Many studies have since shown that hyperplasia and hypertro-
phy both contribute to WAT mass expansion in obesity. Some
studies show that hyperplasia only occurs in early-onset obesity,
prior to the developmental establishment of adipocyte number
(Lemonnier, 1972; Salans et al., 1973). Others have shown that
increased adipocyte number can also contribute to WAT mass
gain in adult-onset obesity, including both genetic (Hirsch and
Batchelor, 1976; Johnson and Hirsch, 1972; Johnson et al.,
1971) and dietary-induced obesity (Ellis et al., 1990; Faust
et al., 1978; Faust et al., 1984; Klyde and Hirsch, 1979). It is
also important to note that several of these studies show that
hyperplastic WAT growth is not restricted to severe obesity.
The studies referenced above and numerous others confirm
that there is often an increase in adipocyte number in obesity,
but the results from these studies have been varied, and the pre-
cise contribution of increased adipocyte number to obesity in
different contexts remains unclear.
Several potential explanations exist, both experimental and
biological, for the disparate results with regard to adipocyte
hyperplasia in obesity. Previous attempts to directly assess
adipocyte production in vivo have taken two approaches. One
is to collagenase digest WAT to liberate single cells, float mature
adipocytes, and quantify the amount of newly synthesized DNA
in the adipocyte fraction, usually via incorporation of thymidineCell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc. 9
Figure 1. Identification of Mature Adipocyte Nuclei In Situ
Images of whole mounted white adipose tissue. The lipid is stained with
LipidTOX (green), the plasma membrane with CellMask Orange (red), and the
nuclei with DAPI (blue). Most nuclei in WAT are in close proximity to lipid
droplets. Therefore, accurate identification of adipocyte nuclei (white arrow-
heads) from nonadipocyte nuclei (yellow arrowheads) requires staining of the
plasma membrane. Nuclei that are not separated from the lipid droplets by a
plasma membrane are the mature adipocyte nuclei. Scale bars = 25 mm.
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has been shown that other cell types, such as macrophages,
may contaminate the floating fraction to confound results
(Tchoukalova et al., 2012). The alternative approach is to label
newly synthesized DNA and then determine the location of the
new nuclei in situ, via autoradiography or immunohistochemistry
(Joe et al., 2009; Miller et al., 1984). This technique is problem-
atic, as the majority of adipocytes within a single WAT section
will not display a nucleus, due to the relatively large size of the
cell compared to the nucleus. In addition, while adipocytes
compose the vast majority of WAT mass/volume, they account
for less than 20% of the total cells in WAT (Eto et al., 2009).
Therefore, the majority of nuclei in a WAT section belong to
nonadipocytes that lie in close proximity to the adipocyte lipid
droplet. Due to these issues, the association of a labeled nucleus
with a particular adipocyte can only be made after ruling out the
presence of a plasma membrane between the nucleus and the
adipocyte lipid droplet through electron microscopy or plasma
membrane labeling (Figure 1).
Other indirect methods have been used to assess adipocyte
formation in adult animals in vivo. One approach is to determine
adipocyte hyperplasia by extrapolating the total number of adi-
pocytes from the average size of adipocytes—determined by
direct measures of cell sizing or average diameter via histol-
ogy—and the total weight/volume of the WAT depot (Hirsch
and Han, 1969; Jo et al., 2009). A more recent genetic approach
has used the AdipoChaser mouse to directly label all mature
adipocytes and then assess the formation of nonlabeled adipo-
cytes (Wang et al., 2013). While these methods provide good
estimates of adipocyte number and allow indirect tracing of
adipocyte formation, respectively, they do not inform on the
timing of the signals that initiate adipogenesis. Rather, they
can only be used to measure adipocyte formation after differen-
tiation has progressed enough to allowmorphological character-
ization of the new adipocytes.
Recent studies of the depot-specific responses to high-fat
diet (HFD) feeding highlight the importance of the experimental
approach taken to study hyperplasia in vivo. A study that
assessed adipocyte hyperplasia via immunohistochemical anal-
ysis of incorporation of the thymidine analog bromodeoxyuridine
(BrdU) concluded that SWAT undergoes more hyperplastic10 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.growth than VWAT (Joe et al., 2009). However, the study of
hyperplasia in response to HFD with the AdipoChaser mouse
demonstrated that a significant number of new adipocytes
form in VWAT after 8 weeks of HFD feeding (Lee et al., 2012;
Wang et al., 2013), but there is little to no contribution of new
adipocytes to the increase in SWAT mass through at least
12 weeks of HFD feeding (Wang et al., 2013). While timing differ-
ences between these studies likely contribute to some of the dis-
crepancies, these data suggest that despite increased cellular
proliferation in SWAT, adipogenesis is restricted to VWAT at
the onset of diet-induced obesity.
Although experimental limitations have made it difficult to
accurately and reproducibly determine the precise contribution
of hyperplastic WAT growth to different obesogenic contexts,
the breadth of studies implicating increased adipocyte number
as a contributor to WAT mass accumulation indicate that it is
an important depot-dependent component of obesity that is
influenced by a host of factors, including species, mouse strain,
sex, and obesogenic stimulus (genetic, dietary, etc.). However,
the mechanisms that control adipogenesis in obesity are not
clear. Whether increased adipocyte number is induced in adult-
hood or earlier, the similar turnover rates of adipocytes in obese
and nonobese adults (Spalding et al., 2008) suggest that
increases in adipocyte number result from either transient induc-
tion(s) of adipogenesis that alters the adipocyte set point, mini-
mal increases in adipocyte formation over long periods, or
both of these mechanisms. Several studies have suggested
that new adipocytes form several weeks after the initiation of
HFD feeding, as adipocytes begin to reach their maximal size
(Faust et al., 1978; Joe et al., 2009; Wang et al., 2013). Based
on this concept, it has been hypothesized that an adipogenic
signal is generated as mature adipocytes reach maximal size
and can no longer expand tomeet the increased demand for lipid
storage (Faust et al., 1978). While the nature of this potential reg-
ulatory mechanism in obesity is not known, it has been shown
that factors secreted bymature adipocytes can affect adipogen-
esis (Janke et al., 2002).
There are many different paths that can lead to obesity, with
synergy between genetics and environment playing a pivotal
role. It is important to understand how adipocyte number is regu-
lated in WAT, as adipocyte number and size are the two main
contributors to WAT mass. While increased adipocyte size is
associated with insulin resistance (Salans et al., 1968), the phys-
iological ramifications of increased adipocyte number in obesity
are not clear. Increased adipocyte generation has been postu-
lated to be the mechanism that leads to increased insulin sensi-
tivity with thiazolidinedione (TZD) treatment (Lehmann et al.,
1995), suggesting that having more adipocytes can be benefi-
cial. However, the morbidly obese have increased adipocyte
number and significantly worse health outcomes (Calle et al.,
1999). In order to determine how increased adipocyte number
impacts the development of obesity-associated disease, we
must understand the processes that regulate adipocyte number
in vivo. However, the majority of our understanding of the pro-
cess of adipogenesis has come from in vitro studies.
In Vitro Adipogenesis
Several approaches have been taken to study adipogenesis in
cell culture. Rodbell pioneered the digestion of rodent WAT to
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(Rodbell, 1964). Subsequently, culturing of the remaining nona-
dipocyte cell fraction, referred to as the stromal-vascular fraction
(SVF), resulted in the differentiation of adherent fibroblastic SVF
human cells into lipid-laden cells after 2 months (Ng et al., 1971).
These studies were the first to describe the presence of a
WAT-resident adipogenic stromal cell population appropriate
for the study of human adipogenesis in cell culture. Today, the
culture of whole SVF is routinely applied to tissue engineering
(Lin et al., 2010; Zuk et al., 2001), where the resulting adherent
cells are referred to as adipocyte-derived stem (stromal) cells
(ADSCs) or adipose stem cells (ASCs). Several studies have
demonstrated that ADSC/ASC cultures can differentiate into
many cell types in vitro, including adipocytes, osteoblasts, chon-
drocytes, and skeletal myocytes (Gimble et al., 2007). However,
analysis of cell surface marker expression indicates that ADSC/
ASC cultures are a heterogeneous population of cells, even after
several rounds of passage (Guilak et al., 2006; Mitchell et al.,
2006; Zuk et al., 2002). Clonal analysis and colony formation
studies have shown that most of the differentiation of ADSC/
ASC cultures toward any particular lineage is provided by sub-
populations of cells that are restricted to one or two fates, with
very few cells displaying multipotency (Mitchell et al., 2006).
Adherent cell populations are even more restricted in vivo, with
mouse ADSCs readily forming chondrocytes and bone but
displaying little or no de novo adipogenic capacity when trans-
planted in mice (Zheng et al., 2006). Moreover, human ADSCs
require prior stimulation of adipogenesis in vitro to form
adipocytes after transplantation into severe combined immuno-
deficiency (SCID) mice (Hong et al., 2006). These findings
demonstrate that selection of WAT-resident SVF cells by adher-
ence alone results in a mixed population of cells, with the major-
ity of cells unable to form adipocytes in vitro and no significant
adipogenic activity in vivo. Regardless of whether this limited
adipogenic capacity is the result of insufficient enrichment of
adipocyte precursors or alterations in cell function during pro-
longed cell culture (Boquest et al., 2005), these results suggest
that the study of adherent whole SVF provides little insight into
the adipocyte cellular lineage in vivo.
In another approach to in vitro adipogenesis, adipogenic
clones of the spontaneously immortalized Swiss mouse 3T3
fibroblast cell line, including 3T3L1 and 3T3-F442A, were iso-
lated and shown to accumulate lipid after being maintained at
confluence in culture (Green and Kehinde, 1975, 1976; Green
and Meuth, 1974). Many factors have since been demonstrated
to affect adipogenesis of these cells, but the addition of
insulin (Green and Kehinde, 1975), 1-methyl-3-isobutyl xanthine
(IBMX) (Russell and Ho, 1976), and glucocorticoid (e.g., dexa-
methasone) (Miller et al., 1978; Rubin et al., 1978) enhances adi-
pogenesis, and these factors together are now considered the
common adipogenic cocktail. However, it should be noted that
while this adipogenic cocktail is effective in rodentmodels of adi-
pogenesis, the differentiation of human primary cells and cell
lines has required the addition of PPARg agonists or indometh-
acin, which alters prostaglandin synthesis and, similar to PPARg
agonists, can drive lipid accumulation even in mesenchymal
stem cells that are not committed to an adipogenic lineage (Sty-
ner et al., 2010). The requirement for these compounds limits the
mechanistic studies of adipogenesis (Church et al., 2012) andsuggests that improved culture models are required for human
adipogenesis in vitro, either via improved enrichment of adipo-
genic cell populations, isolation procedures, and/or identifica-
tion of improved culture conditions.
Study of 3T3 cell lines has provided a wealth of knowledge
on the molecular pathways that regulate adipogenesis. To
summarize, a well-characterized transcription factor cascade
leads to the induction of the transcription factor PPARg2 (Tonto-
noz et al., 1994), which drives adipogenesis through the
induction of several lipogenic genes (for review see Rosen and
MacDougald, 2006). In addition to characterizing the adipogenic
transcription factor cascade, cell culture studies have implicated
a host of signaling factors as regulators of adipogenesis,
including bonemorphogenic proteins (BMPs), WNTs, and insulin
growth factors (IGFs) (reviewed in Cristancho and Lazar, 2011;
Tang and Lane, 2012). However, the study of adipogenesis
in vitro does not inform if or when specific factors participate in
adipogenesis in vivo. For example, the in vivo adipogenic role
for the cyclic AMP and glucocorticoid-mediated signaling path-
ways, which are stimulated by IBMX and dexamethasone,
respectively, during induction of adipogenesis in vitro, remains
unclear. The gene expression program induced by the adipo-
genic cocktail in 3T3L1 cells mirrors that observed in developing
murine SWAT (Birsoy et al., 2011), but there are a number of dif-
ferences between 3T3L1 adipogenesis and the gene programs
observed in adult mouseWAT (Soukas et al., 2001). Additionally,
while overt lipid filling is observed within 48 hr during in vitro adi-
pogenesis, rodent adipocyte precursors may take more than
35 days to fill with lipid in vivo (Greenwood and Hirsch, 1974;
Wang et al., 2013). Based on these observations, it is possible
that adipogenesis in vivo is regulated by unappreciated molecu-
lar pathways that are modulated well in advance of overt lipid
filling. Therefore, understanding the timing of adipogenesis in
various physiological contexts is necessary for focused study
of the molecular mechanisms regulating adipocyte formation
in vivo. Recent studies have identified in vivo adipocyte precur-
sor cells as subpopulations of WAT SVF, allowing for directed
study of the temporal, cellular, and molecular mechanisms that
regulate in vivo adipogenesis.
Adipocyte Precursors In Vivo
Several studies have now isolated different cell subpopulations
from total WAT SVF in an effort to identify adipocyte precursors.
Initial studies that used magnetic bead separation to isolate
cell subpopulations from human WAT SVF found that the
CD31:CD34+ population is enriched for adipogenic capacity
(Sengene`s et al., 2005), but appropriate markers for significant
further enrichment have not been clearly identified in human
WAT.
Adipogenic cell populations have been characterized in
greater detail from mice using flow cytometry and fluores-
cence-activated cell sorting (FACS) to isolate populations of
live cells based on expression of cell surface proteins. Although
this technology has long been used to characterize cell popula-
tions in stem cell fields and immunobiology, it has only recently
been applied to WAT for identification of adipogenic SVF sub-
populations through prospective analysis of adipogenesis both
ex vivo in adipogenic cell culture conditions and in vivo following
transplantation (Be´ne´zech et al., 2012; Daquinag et al., 2011; LeeCell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc. 11
Figure 2. A Model of In Vivo Adipogenesis
A schematic representation of the adipocyte
cellular lineage is shown. The defined lineage, cell
surface, and transcriptional markers for each cell
type are shown below each listed cell type. Posi-
tive markers are shown in blue, while negative
markers are shown in gold. The question marks
highlight that it is currently unclear if the adipocyte
progenitor population contains self-renewing
adipocyte stem cells or if the adipocyte pro-
genitors are repopulated by another, unidentified
population of adipocyte stem cells in adults.
Cell Metabolism
Perspectiveet al., 2012; Rodeheffer et al., 2008; Tang et al., 2008). In this
approach, the SVF is labeled with fluor-conjugated antibodies
recognizing cell-surface proteins to allow for separation and
isolation of adipose stromal cell subpopulations. Using FACS,
two stromal cell populations with in vitro adipogenic capacity
were identified within murine subcutaneousWAT. These popula-
tions are negative for blood and endothelial specific markers
(CD45, CD31, Ter119), positive for mesenchymal and stem cell
markers (CD29, CD34, Sca-1), and are separated based on their
expression of CD24. One population, characterized by the cell
surface marker profile CD45;CD31;Ter119;CD29+;CD34+;
Sca-1+;CD24 (CD24), is highly adipogenic in culture yet has
restricted adipogenic capacity when transplanted into the
underdeveloped perigonadal (VWAT) adipose tissue of lipody-
strophic A-ZIPmice. In contrast, the other population, character-
ized by the cell surface marker profile CD45;CD31;Ter119;
CD29+;CD34+;Sca-1+;CD24+ (CD24+), is highly adipogenic in
culture and capable of considerable expansion prior to differen-
tiation, leading to reconstitution of an entire functional WAT
depot with correction of hyperglycemia and hyperinsulinemia
when transplanted into fatless mice (Rodeheffer et al., 2008).
Through flow cytometry analysis of CD24+ cells following
transplantation into A/Zip mice, it was demonstrated that the
CD24+ population gives rise to the CD24 population in vivo,
while the CD24 population does not produce CD24+ cells.
When these populations are transplanted into a nonadipogenic
tissue microenvironment in vivo, the CD24 population retains
a low adipogenic capacity that fails to correct A/Zip hyperglyce-
mia, while the CD24+ population is surprisingly not adipogenic
(Berry and Rodeheffer, 2013). Based on these results, we have
proposed the following model for in vivo adipogenesis (Figure 2).
The CD24+ population contains early adipocyte progenitors that
have high adipogenic capacity within the WAT microenviron-
ment and are capable of extensive expansion prior to terminal
differentiation but require the WAT microenvironment for their
adipogenic capacity. During adipogenesis, the CD24+ adipocyte
progenitor loses CD24 expression to become CD24 pre-
adipocytes. The CD24 preadipocyte population contains cells12 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.committed to the adipocyte lineage,
which have low adipogenic capacity that
is not dependent on the WAT microenvi-
ronment.
Consistent with adipogenic commit-
ment, the CD24 cell population is en-
riched for expression of Pparg2 and
C/EBPa (Berry and Rodeheffer, 2013).These data suggest that the CD24+ and CD24 cell populations
contain the adipocyte precursors from early progenitors with
substantial capacity to expand prior to differentiation to cells
that are primed to fill with lipid to form mature adipocytes. Since
mature adipocytes are postmitotic, adipocyte precursors must
exit the cell cycle at some point during adipogenesis. However,
it is unclear precisely where in the adipocyte lineage cells
become postmitotic, and it may be difficult to determine given
the rapid differentiation of CD24+ cells into CD24 cells in vivo
(Berry and Rodeheffer, 2013). In vitro, cultured confluent preadi-
pocytes undergo two rounds of synchronous cell division before
permanently exiting the cell cycle in a process referred to as
mitotic clonal expansion (MCE) (Tang et al., 2003). However, it
remains unclear if MCE is an important component of hyper-
plastic WAT growth in vivo. Given the relatively high abundance
of CD24 adipocyte precursors in WAT depots (Figure 3), it is
possible that postmitotic adipocyte precursors contribute signif-
icantly to increased adipocyte number. At the other end of the
lineage, it is unknown if the CD24+ population harbors bona
fide adipocyte stem cells, capable of self-renewal and contrib-
uting mature adipocytes to maintain or expand WAT mass, or
if the CD24+ population is maintained by another, currently
unidentified adult stem cell population. Similar cell populations
are found within all major WAT depots in mouse (Berry and
Rodeheffer, 2013) (Figure 3), suggesting that these adipocyte
precursors play a general role in the maintenance and expansion
of WAT and that differential regulation of these cells leads to the
depot-specific responses observed in obesity.
A benefit of using FACS and flow cytometry to isolate and
analyze adipocyte precursors from WAT is that the technique
is accessible, making use of commercially available reagents.
Additionally, this approach can be applied to any mouse line or
strain, as well as to other species, including human. CD34 has
been shown to be expressed on adipocyte precursors in mice
(Rodeheffer et al., 2008) and has also been used to enrich for adi-
pogenic cells from human WAT SVF (Sengene`s et al., 2005).
However, at least one of the cell surface factors used for the
isolation of mouse adipocyte precursors, Sca-1, does not have
Figure 3. Adipocyte Progenitors in WAT
Depots
CD24+ adipocyte progenitor cells are a distinct
population of WAT-resident stromal cells. Shown
are dot plots of the Lin-:CD29+:CD34+ cell pop-
ulations from the indicated depots. The cells are
present in levels as high at 2% in adult SWAT
depots. Cells with an identical cell surface marker
profile are present in VWAT depots but are less
abundant (perigonadal WAT [GWAT] is shown).
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that the human adipocyte precursors will likely require different
markers for isolation. In addition, these markers do not have
known functions in adipocyte precursor regulation in vivo. For
example, while CD24 and Sca-1 are critical cell surface markers
for identification of murine adipocyte progenitors, mice deficient
in CD24 or Sca-1 do not display overt adipose phenotypes (Niel-
sen et al., 1997; Stanford et al., 1997). Furthermore, the use of
several cell surface markers is currently required to significantly
enrich for adipocyte precursors. A complimentary approach to
studying adipogenesis in vivo is to develop tools based on func-
tional markers of adipogenesis. Toward this end, several genetic
mouse models have been generated.
Genetic Approaches for Studying Adipogenesis In Vivo
Themost widely used genetic factor for studyingWAT in vivo has
been the aP2 promoter, which drives expression of fatty acid
binding protein 4 (FABP4). However, in vitro studies have shown
that aP2 is induced late in adipogenesis (Bernlohr et al., 1985),
and A-Zip mice, which have a block in adipogenesis via expres-
sion of a dominant-negative transcription factor from an aP2
promoter, accumulate more adipocyte precursors (Rodeheffer
et al., 2008). This suggests that aP2 is not necessarily expressed
in adipocyte precursor populations in vivo. In addition, the aP2
promoter is known to drive gene expression in many other tis-
sues and cell lineages, including macrophages (Mullican et al.,
2013). Therefore, other genetic strategies have been employed
to characterize adipocyte precursor populations in vivo.Cell MetabolismPparg was hypothesized to be a ge-
netic marker of adipogenic cells in vivo
due to its expression pattern and role
as the master regulator of adipogenesis
in vitro. To identify Pparg-expressing
cells in vivo, a mouse model was
generated in which a tetracycline transac-
tivator (tTA) gene was knocked into
exon 2 of the Pparg locus. This strain
was crossed to reporter lines under
control of tet-response elements to
show that Pparg-expressing stromal cells
undergo adipogenesis to form WAT dur-
ing development and following transplan-
tation into nude mice (Tang et al., 2008).
Additionally, Tang et al. (2008) concluded
that adipocyte precursors are associated
with adipose tissue vasculature, as GFP-
labeled cells were found lining blood ves-
sels in WAT of Pparg-H2BGFP mice.However, Pparg expression is induced late in adipogenesis
and therefore may not be appropriate for studying the regulation
of early adipogenic events in vivo. A novel preadipocyte determi-
nation factor, Zfp423, was identified through transcriptome
comparison of adipogenic and nonadipogenic clonal sublines
of 3T3 Swiss fibroblasts prior to adipogenic expansion in vitro
(Gupta et al., 2010). Zfp423 is enriched in adipogenic 3T3 sub-
clones and induces adipogenesis in nonadipogenic 3T3 sub-
clones through induction of Pparg2. To elucidate the function
of Zfp423 on adipogenesis in vivo, a mouse that expresses
GFP from the Zfp423 locus was generated (Gupta et al., 2012).
Using these mice, it was demonstrated that FACS purification
of GFP-expressing cells from whole SVF cultures enriched for
cells with adipogenic capacity upon replating. While the role of
Zfp423 in adipogenesis in vivo has yet to be assessed, the isola-
tion of in vivo adipocyte precursors prior to expression of late adi-
pogenic genes (Pparg2, aP2, etc.) using an early functional
marker, such as Zfp423, would facilitate the study of adipogene-
sis in vivo by simplifying the isolation and visualization strategies.
However, the expression of Zfp423 in endothelial cells (Gupta
et al., 2012) precludes the use of Zfp423 as a single marker of
in vivo adipocyte precursors. Regardless, a combination of func-
tional early- and late-stage adipocyte precursor markers would
greatly facilitate the functional analysis of adipogenesis in vivo.
The Developmental Origins of White Adipose Tissue
Although flow cytometry and the previously mentioned genetic
mouse models allow for the study of adipocyte precursor19, January 7, 2014 ª2014 Elsevier Inc. 13
Cell Metabolism
Perspectivepopulations, complete understanding of WAT formation requires
understanding of the lineage(s) adipocytes are derived from dur-
ing development. While adipocytes that form in depots in the
head region have been shown to derive from the neural crest
(Billon et al., 2007; Lemos et al., 2012), the developmental origin
of adipocyte in major WAT depots has not been characterized. It
has long been posited that adipocytes are of mesenchymal
origin, based on their initial formation within connective tissue
(Hammar, 1895), the morphology of adipocyte precursors
(Napolitano, 1963), and the ability of mesenchymal cells to
form adipocytes in culture (Taylor and Jones, 1979). In an effort
to further refine the developmental origin of adipocytes in the
major WAT depots, recent studies have investigated if white
adipocytes are derived from endothelial (Tran et al., 2012) or
hematopoietic (Crossno et al., 2006; Sera et al., 2009) lineages.
Many observations from early work on adipose tissue have
shown that adipocytes form in close proximity to vasculature
(for review see Wassermann, 1965). Additionally, vascular prop-
agation and adipogenesis are closely linked in vivo (Fukumura
et al., 2003; Han et al., 2011; Rupnick et al., 2002). These obser-
vations have led to the hypothesis that adipocytes are derived
from a vascular cell lineage. Recent studies have directly ad-
dressed whether adipocytes are derived from endothelial line-
ages through lineage tracing using the Cdh5 (VE-cadherin)-cre
mouse model. Through analysis of X-gal-stained WAT and BAT
sections from Cdh5-cre:LacZ mice, it was concluded that
mature brown and white adipocytes expressed the LacZ re-
porter andwere therefore derived fromCdh5-expressing precur-
sor cells (Tran et al., 2012). However, use of the LacZ reporter
line for the study of adipose tissue is confounded by the paucity
of cytoplasm in mature adipocytes and the high vascularity of
adipose tissue. In addition, neither the LacZ reporter or GFP re-
porter experiments in this studywere combinedwith direct stain-
ing of endothelial cells to ensure the observed staining was not
due to signal from capillaries in close association withmature ad-
ipocytes.
To overcome the difficulties associated with reporters ex-
pressed in the adipocyte cytoplasm, we crossed the same
Cdh5-cre mouse line to the fluorescent membrane dTomato/
membrane eGFP (mT/mG) reporter mouse. In mT/mG reporter
mice, Cre-mediated excision causes a permanent switch from
expression of plasma membrane-targeted dTomato to plasma
membrane-targeted eGFP (Muzumdar et al., 2007). The dual la-
beling of both non-cre-expressing cells (red fluorescence) and
Cre-expressing cells (green fluorescence) not only permits clear
distinction of Cre tracing via fluorescent microscopy, but also fa-
cilitates cre tracing of SVF cell populations via flow cytometry.
Analysis of adipose depots from Cdh5-cre:mT/mG mice pro-
duced results that conflicted with data from the LacZ tracing,
as all adipocytes and previously characterized adipocyte precur-
sor populations in all major WAT and brown adipose depots re-
mained dTomato+ and eGFP, while vasculature and isolated
CD31+ endothelial cells clearly expressed eGFP due to expres-
sion of cre recombinase from the Cdh5 promoter. This result
was found for both adipocytes generated during normal devel-
opment and in diet-induced obesity (DIO). These results from
Cdh5-cre tracing, coupled with similar findings in another endo-
thelial-driven Cre-recombinase model, the Tie2-cremouse, indi-
cate that adipocytes are not derived from cells of the vascular14 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.endothelium during development or early-onset obesity (Berry
and Rodeheffer, 2013). Both of the mature endothelial cell
markersCdh5 and Tie2 are initially expressed in angioblasts dur-
ing embryonic vasculogenesis, and new endothelial cells are
derived from mature endothelial cells during angiogenesis (Fer-
guson et al., 2005). Thus, the lack of mature adipocyte labeling
in Cdh5-cre and Tie2-cre mice suggests that the close relation-
ship between angiogenesis and adipogenesis in WAT does not
result from regulation of a common progenitor, but is instead
restricted to paracrine crosstalk between adipocyte lineage cells
and vascular cells (Fukumura et al., 2003) to maintain proper
vascularization and WAT morphology.
The hematopoietic lineage has also been proposed as a
potential source of mature adipocytes (McCollough, 1944).
Studies that followed the fate of transplanted bone marrow cells
and genetically labeled myeloid lineage cells found that up to
25% of mature adipocytes isolated through fractionation of
whole WAT come from the hematopoietic lineage under certain
conditions (Crossno et al., 2006; Majka et al., 2010, 2012). These
studies also demonstrated that the floating myeloid lineage-
derived cells were negative for macrophage markers, such as
CD11b, and positive for the adipocyte markers perilipin and adi-
ponectin. They also demonstrated that WAT was luminescent in
HFD-fed mice that received bone marrow transplants from
aP2-Cre;LSL-Luciferase mice (Majka et al., 2012). However,
in a separate study, in situ analysis demonstrated that WAT-
resident bone marrow transplant-derived cells expressed multi-
ple macrophage markers and did not express markers of mature
adipocytes (Koh et al., 2007). This study also showed that the
bonemarrow-derived cells formed classic crown-like structures,
indicative of macrophages responding to adipocyte death.
Similar results were found in noninjury conditions by Vav1-Cre
lineage tracing of hematopoietic stem cell-derived populations
(Berry and Rodeheffer, 2013). The data from the different groups
are contradictory with regard to the ability of the hematopoietic
lineage to contribute to mature adipocytes. However, the case
for a hematopoietic origin of mature adipocytes is largely based
on the identification of hematopoetic lineage-derived cells in the
floating WAT fraction, which is often contaminated with macro-
phages (Tchoukalova et al., 2012). Furthermore, the additional
evidence for a hematopoietic origin of adipocytes used the
aP2-cre model, which has been shown to drive cre expression
directly in macrophages as well as mature adipocytes (Mao
et al., 2009).
Although adipocytes are not normally of endothelial or hema-
topoetic origin, cells with the morphology of differentiating
preadipocytes reside within the vascular compartment (Cinti
et al., 1984; Wassermann, 1926). Additionally, vascular-associ-
ated Pparg-expressing cells have been shown to express the
pericyte (mural cell) markers PdgfRb, NG2, and aSMA (Tang
et al., 2008). These observations have led to the hypothesis
that a subpopulation of pericytes is adipocyte precursors (Cinti
et al., 1984). In support of this theory, whole WAT depots stain
positive for b-galactosidase expression in PdgfRb-cre:R26R-
LacZmice, and PDGFRb+ cells can form adipocytes when trans-
planted into mice (Tang et al., 2008). The possibility that a sub-
population of pericytes function as adipocyte precursors is
appealing given that the well-characterized interplay between
pericytes and endothelial cells during vascular growth is
Table 1. Cell Surface Markers of WAT-Resident Adipocyte
Precursors and Adipogenic Cell Populations Found in Other
Murine Tissues
Tissue Positive Negative









Brown Adiposef CD34, Sca1, CD29 CD31, CD45







Skinj CD34, Sca1, CD29,
CD24*
CD31, CD45
Bone Marrowk Sca1, PdgfRa CD45, Ter119
*CD24 is expressed by adipogenic cells in embryonic WAT, but is only
expressed by the early adipocyte progenitors in adulthood, when they
represent a rare subset of the adipocyte precursors.
a(Rodeheffer et al., 2008).
b(Berry and Rodeheffer, 2013).
c(Be´ne´zech et al., 2012).
d(Tang et al., 2008).
e(Daquinag et al., 2011).
f(Sanchez-Gurmaches et al., 2012).
g(Joe et al., 2009).
h(Uezumi et al., 2010).
i(Birbrair et al., 2013).
j(Festa et al., 2011).
k(Morikawa et al., 2009).
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and adipogenesis in vivo (Fukumura et al., 2003; Rupnick
et al., 2002).
Platelet-derived growth factor receptor alpha (PdgfRa) has
also been implicated in the adipocyte lineage, as it is expressed
by adipogenic stromal cells from muscle and craniofacial adi-
pose tissue that share several cell surface markers of CD24+
and CD24 adipocyte precursors (Joe et al., 2010; Lemos
et al., 2012). Using PdgfRa-cre:mT/mG mice, we showed that
all adipocytes in all major WAT depots are derived from
PdgfRa-expressing precursors (Berry and Rodeheffer, 2013).
This result supports the model for adipogenesis presented
above, as the CD24+ adipocyte progenitor cells and CD24 pre-
adipocytes are the only adipogenic SVF populations that
express PdgfRa (Berry and Rodeheffer, 2013). Additionally,
WAT-resident PdgfRa-expressing cells have recently been
shown to proliferate and differentiate into brown-like adipocytes
in response to b-3-adrenergic agonist treatment and white adi-
pocytes in response to high-fat diet feeding (Lee et al., 2012).
Taken together, these results indicate that mature adipocytes
are derived from the CD24+ and CD24 adipocyte precursors
in the formation, maintenance, expansion, and remodeling of
WAT. However, the tracing of mature adipocytes by PdgfRa
does not inform on their developmental origin, as PdgfRa is
expressed in adipocyte precursors (Berry and Rodeheffer,
2013). Therefore, the precise origin of white adipocytes remains
uncharacterized.Utilization of Mouse Models for Genetic Manipulation of
Adipocyte Precursor Cells
The studies detailed above implicate Pparg-tTA, PdgfRb-cre,
and PdgfRa-cremice as candidate models for genetic targeting
of adipocyte precursor cells in vivo. However, each of these
models has inherent limitations. Primarily, none of these models
are capable of specifically targeting adipocyte precursor cells.
The Pparg-tTA model lacks specificity, as the tTA cassette
was knocked into exon 2 of the Pparg locus, which is shared
by at least two isoforms of PPARg (PPARg1 and PPARg2) that
are generated through alternative splicing (Tang et al., 2008;
Tontonoz et al., 1994; Zhu et al., 1995). Although PPARg2 is
expressed specifically in adipose tissue (Tontonoz et al., 1994),
PPARg1 is expressed in many cell types, including macro-
phages, colon epithelium, liver, heart, and adipose (Hevener
et al., 2007). This lack of specificity limits the interpretation of
adipocyte precursor cell function and localization using this
model. Furthermore, Pparg knockin mice are heterozygous for
Pparg. As Pparg heterozygosity is known to produce adipose
phenotypes (Miles et al., 2000), data obtained from these mice
need to be confirmed in wild-type backgrounds.
Both PdgfRa-cre and PdgfRb-cre mouse lines are also
complicated by nonspecificity. While PdgfRb is a well-charac-
terized marker of pericytes, it is only expressed on a subset of
pericytes. More importantly, PdgfRb+ pericytes are not specific
to WAT, as they are found throughout the body and have
been well characterized as important neurovascular regulatory
cells (Dore-Duffy, 2008). Through flow cytometry analysis of
PdgfRa-cre:mT/mG mice, we found that PdgfRa-cre labels
small populations of CD45+ and CD31+ cells in WAT (Berry
and Rodeheffer, 2013). PdgfRa is also known to label glial line-
age cells in the brain and retina (Rivers et al., 2008). Finally, the
use of any model for genetic manipulation of adipocyte precur-
sor cells must take into consideration that cells with similar cell
surface marker profiles and functions have been located in
brown adipose tissue (BAT) (Sanchez-Gurmaches et al., 2012),
skeletal muscle (Birbrair et al., 2013; Joe et al., 2010; Uezumi
et al., 2010), skin (Festa et al., 2011), and bone marrow (Mori-
kawa et al., 2009) (Table 1).
The lack of specificity of these genetic models complicates
the targeting of white adipocyte precursor cells and high-
lights that care must be taken in interpreting studies performed
with these genetic models. It is possible that estrogen-
responsive versions of PdgfR-cre mice, such as the recently
published PdgfRa-ERCre mouse model, may allow for less
disruptive genetic manipulation (Lee et al., 2012). However,
given the known effects of estrogen on WAT (Mattsson and
Olsson, 2007), experiments involving tamoxifen must be care-
fully considered. By using adipocyte precursor targeting models
(PdgfRa-cre, PdgfRa-ERCre) in conjunction with mouse
models specifically labeling mature adipocytes (Adiponectin-
cre) (Eguchi et al., 2011), it will theoretically be possible to
distinguish whether observed phenotypes are the result of
gene function within adipocyte precursors or mature adipo-
cytes. While the recent advances in tools and methodologies
will surely prompt a variety of directed studies of in vivo adipo-
genesis, interpretation of data must consider possible limita-
tions of the models that are used to study adipocyte precursor
function in vivo.Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc. 15
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Although the majority of WAT mass is composed of classical
lipid-storing white adipocytes, studies have shown that in-
creasing sympathetic tone through chronic cold exposure
(Cousin et al., 1992) or direct stimulation of b3-adrenergic recep-
tors via agonist treatment (Ghorbani and Himms-Hagen, 1997)
results in the presence of lipolytic, multilocular adipocytes within
classical WAT depots in rodents. Due to their morphological and
functional similarities to classical brown adipocytes and their
location within WAT depots, these cells have been termed beige
or brite adipocytes. Since genetic manipulations resulting in
large increases in the number of beige adipocytes within WAT
have been shown to protect against the development of obesity
(Seale et al., 2011), beiging of WAT may be a potential treatment
for obesity. However, themechanisms of beige adipocyte forma-
tion are an area of current debate.
The two proposed mechanisms of beige adipocyte formation
are transdifferentiation of mature white adipocytes to acquire a
multilocular lipolytic phenotype and de novo formation of beige
adipocytes from adipocyte precursor cells (Lee and Cowan,
2013). A recent study using Ucp1-CreER:tdRFP (Ucp1-Tracer)
mice to induce permanent fluorescent labeling of beige adipo-
cytes provided evidence for the transdifferentiation of mature
adipocytes. This study showed that the labeling of beige adipo-
cytes only during cold treatment resulted in RFP+ adipocytes ex-
pressing white adipocyte genes after several weeks of recovery.
A second round of chronic cold treatment without relabeling re-
sulted in the presence of RFP+ beige adipocytes (Rosenwald
et al., 2013). These experiments indicate that beige adipocytes
can transdifferentiate to take on a white phenotype and that
‘‘whitened’’ beige adipocytes can reacquire their beige pheno-
type under beiging conditions. A separate study utilizing the
AdipoChaser mouse concluded that the majority of beige adipo-
cytes arise from de novo differentiation of adipocyte precursors.
In these experiments, mature adipocytes in the AdipoChaser
mice were permanently labeled prior to challenge with either
cold exposure or b3-adrenergic receptor agonist treatment.
Analysis of WAT depots revealed that most newly formed beige
adipocytes were not labeled and were therefore not the result of
transdifferentiation of previously labeled mature white adipo-
cytes (Wang et al., 2013). While the latter study did not directly
follow the differentiation of adipocyte precursors into beige adi-
pocytes, transplantation studies have shown that FACS-isolated
PDGFRa+ adipocyte precursors are capable of forming both
white adipocytes in response to HFD and brown adipocytes in
response to b3-adrenergic receptor agonist treatment (Lee
et al., 2012), further supporting the model of de novo beige
adipocyte formation from adipocyte precursors.
Amajor question that has yet to be addressed regarding the de
novo formation of beige adipocytes is whether these cells arise
from identical or distinct populations of PdgfRa-expressing
precursors residing within WAT. Tracing of mature WAT using
Myf5-cre, which labels brown adipocytes (Seale et al., 2008),
has revealed that a subpopulation of white adipocytes are also
traced by this promoter (Sanchez-Gurmaches et al., 2012).
This led to the hypothesis that beige adipocytes arise from
Myf5-cre-traced adipocyte precursors. However, b3-adrenergic
receptor agonist treatment does not selectively increase the
number of Myf5-cre-traced adipocyte precursors in WAT (San-16 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.chez-Gurmaches et al., 2012). Additionally, adipocytes derived
from the differentiation of non-Myf5-cre-traced precursors dis-
played gene expression profiles more similar to brown and beige
cells than adipocytes derived from Myf5-cre-traced precursors
(Shan et al., 2013). While these results indicate that Myf5 does
not distinguish a population of beige adipocyte precursors, it is
unclear if there is a dedicated population of beige adipocyte pre-
cursors for which markers have yet to be identified or if the white
adipocyte precursors described above are bipotent, capable of
giving rise to beige and white adipocytes.
Conclusions
In the last 100 years, the field of adipose tissue biology has
transitioned from gross observation of WAT and molecular char-
acterization of adipogenesis in vitro to the identification and
characterization of in vivo adipocyte lineage cells. This process
has provided a wealth of knowledge about the temporal and
cellular mechanisms of WAT accumulation. However, a lack of
directed methodologies and genetic tools has limited our ability
to definitively determine the WAT-intrinsic mechanisms that
regulate adipocyte size and number in vivo. With the advent of
new experimental models and the application of methodologies
to the field of adipose tissue biology, we now have the opportu-
nity to study theWAT-intrinsic molecular mechanisms regulating
WAT mass in vivo.
While future studies will identify more specific markers of
in vivo adipocyte precursors, the contributions of many groups
over the last few decades have provided thorough characteriza-
tion of many pro- and anti-adipogenic pathways regulating
in vitro adipogenesis. The application of genetic mouse models
now allows for the study of these pathways during WAT growth
and remodeling in vivo. As the depot and cellular mechanisms of
WAT accumulation greatly affect the pathogenesis of obesity,
the study of WAT expansion in vivo has the potential to identify
novel therapeutic targets for obesity. This would not only
improve the health of those suffering from obesity and obesity-
associated pathologies, but also alleviate the economic burden
that is a result of this disease.
ACKNOWLEDGMENTS
The authors thank Christopher D. Church for critical reading of the manuscript.
This work was supported by American Diabetes Association Award 7-12-JF-
46, DERC pilot project grant DK045735, State of Connecticut stem cell grant
M140291, and NIDDK grant DK090489 to M.S.R.
REFERENCES
Anderson, D.B., and Kauffman, R.G. (1973). Cellular and enzymatic changes in
porcine adipose tissue during growth. J. Lipid Res. 14, 160–168.
Be´ne´zech, C., Mader, E., Desanti, G., Khan, M., Nakamura, K., White, A.,
Ware, C.F., Anderson, G., and Caaman˜o, J.H. (2012). Lymphotoxin-b receptor
signaling through NF-kB2-RelB pathway reprograms adipocyte precursors as
lymph node stromal cells. Immunity 37, 721–734.
Berg, W. (1911). The development of human fat. Z. Morph. Anthrop. 13.
Bernlohr, D.A., Bolanowski, M.A., Kelly, T.J., Jr., and Lane, M.D. (1985).
Evidence for an increase in transcription of specific mRNAs during differentia-
tion of 3T3-L1 preadipocytes. J. Biol. Chem. 260, 5563–5567.
Berry, R., and Rodeheffer, M.S. (2013). Characterization of the adipocyte
cellular lineage in vivo. Nat. Cell Biol. 15, 302–308.
Cell Metabolism
PerspectiveBillon, N., Iannarelli, P., Monteiro, M.C., Glavieux-Pardanaud, C., Richardson,
W.D., Kessaris, N., Dani, C., and Dupin, E. (2007). The generation of adipo-
cytes by the neural crest. Development 134, 2283–2292.
Birbrair, A., Zhang, T., Wang, Z.M., Messi, M.L., Enikolopov, G.N., Mintz, A.,
and Delbono, O. (2013). Skeletal muscle pericyte subtypes differ in their differ-
entiation potential. Stem Cell Res. (Amst.) 10, 67–84.
Birsoy, K., Berry, R., Wang, T., Ceyhan, O., Tavazoie, S., Friedman, J.M., and
Rodeheffer, M.S. (2011). Analysis of gene networks in white adipose tissue
development reveals a role for ETS2 in adipogenesis. Development 138,
4709–4719.
Boquest, A.C., Shahdadfar, A., Frønsdal, K., Sigurjonsson, O., Tunheim, S.H.,
Collas, P., and Brinchmann, J.E. (2005). Isolation and transcription profiling of
purified uncultured human stromal stem cells: alteration of gene expression
after in vitro cell culture. Mol. Biol. Cell 16, 1131–1141.
Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C., and Heath, C.W., Jr.
(1999). Body-mass index and mortality in a prospective cohort of U.S. adults.
N. Engl. J. Med. 341, 1097–1105.
Carey, V.J., Walters, E.E., Colditz, G.A., Solomon, C.G., Willett, W.C., Rosner,
B.A., Speizer, F.E., and Manson, J.E. (1997). Body fat distribution and risk of
non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study.
Am. J. Epidemiol. 145, 614–619.
Church, C., Horowitz, M., and Rodeheffer, M. (2012). WAT is a functional
adipocyte? Adipocyte 1, 38–45.
Cinti, S. (2005). The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids
73, 9–15.
Cinti, S., Cigolini, M., Bosello, O., and Bjo¨rntorp, P. (1984). A morphological
study of the adipocyte precursor. J. Submicrosc. Cytol. 16, 243–251.
Clara, M. (1927a). Contribution to the study of the so-called adipose tissue of
man. Monit. Zool. Ital. 38.
Clara, M. (1927b). The adipose tissue of birds. Z. Anat. Entwicklungsge-
schicte 69.
Cousin, B., Cinti, S., Morroni, M., Raimbault, S., Ricquier, D., Pe´nicaud, L., and
Casteilla, L. (1992). Occurrence of brown adipocytes in rat white adipose tis-
sue: molecular and morphological characterization. J. Cell Sci. 103, 931–942.
Cristancho, A.G., and Lazar, M.A. (2011). Forming functional fat: a growing un-
derstanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 12, 722–734.
Crossno, J.T., Jr., Majka, S.M., Grazia, T., Gill, R.G., and Klemm, D.J. (2006).
Rosiglitazone promotes development of a novel adipocyte population from
bone marrow-derived circulating progenitor cells. J. Clin. Invest. 116, 3220–
3228.
Daquinag, A.C., Zhang, Y., Amaya-Manzanares, F., Simmons, P.J., and Kolo-
nin, M.G. (2011). An isoform of decorin is a resistin receptor on the surface of
adipose progenitor cells. Cell Stem Cell 9, 74–86.
Dore-Duffy, P. (2008). Pericytes: pluripotent cells of the blood brain barrier.
Curr. Pharm. Des. 14, 1581–1593.
Drøyvold, W.B., Nilsen, T.I., Kru¨ger, O., Holmen, T.L., Krokstad, S., Midthjell,
K., and Holmen, J. (2006). Change in height, weight and bodymass index: Lon-
gitudinal data from the HUNT Study in Norway. Int J Obes (Lond) 30, 935–939.
Eguchi, J., Wang, X., Yu, S., Kershaw, E.E., Chiu, P.C., Dushay, J., Estall, J.L.,
Klein, U., Maratos-Flier, E., and Rosen, E.D. (2011). Transcriptional control of
adipose lipid handling by IRF4. Cell Metab. 13, 249–259.
Ellis, J.R., McDonald, R.B., and Stern, J.S. (1990). A diet high in fat stimulates
adipocyte proliferation in older (22 month) rats. Exp. Gerontol. 25, 141–148.
Eto, H., Suga, H., Matsumoto, D., Inoue, K., Aoi, N., Kato, H., Araki, J., and
Yoshimura, K. (2009). Characterization of structure and cellular components
of aspirated and excised adipose tissue. Plast. Reconstr. Surg. 124, 1087–
1097.
Faust, I.M., Johnson, P.R., and Hirsch, J. (1977a). Adipose tissue regeneration
following lipectomy. Science 197, 391–393.
Faust, I.M., Johnson, P.R., and Hirsch, J. (1977b). Surgical removal of adipose
tissue alters feeding behavior and the development of obesity in rats. Science
197, 393–396.Faust, I.M., Johnson, P.R., Stern, J.S., and Hirsch, J. (1978). Diet-induced
adipocyte number increase in adult rats: a new model of obesity. Am. J.
Physiol. 235, E279–E286.
Faust, I.M., Miller, W.H., Jr., Sclafani, A., Aravich, P.F., Triscari, J., and Sulli-
van, A.C. (1984). Diet-dependent hyperplastic growth of adipose tissue in
hypothalamic obese rats. Am. J. Physiol. 247, R1038–R1046.
Ferguson, J.E., 3rd, Kelley, R.W., and Patterson, C. (2005). Mechanisms of
endothelial differentiation in embryonic vasculogenesis. Arterioscler. Thromb.
Vasc. Biol. 25, 2246–2254.
Festa, E., Fretz, J., Berry, R., Schmidt, B., Rodeheffer, M., Horowitz, M., and
Horsley, V. (2011). Adipocyte lineage cells contribute to the skin stem cell niche
to drive hair cycling. Cell 146, 761–771.
Flynn, E.J., 3rd, Trent, C.M., and Rawls, J.F. (2009). Ontogeny and nutritional
control of adipogenesis in zebrafish (Danio rerio). J. Lipid Res. 50, 1641–1652.
Foster, M.T., Shi, H., Seeley, R.J., and Woods, S.C. (2010). Transplantation or
removal of intra-abdominal adipose tissue prevents age-induced glucose
insensitivity. Physiol. Behav. 101, 282–288.
Fox, K., Peters, D., Armstrong, N., Sharpe, P., and Bell, M. (1993). Abdominal
fat deposition in 11-year-old children. Int. J. Obes. Relat. Metab. Disord. 17,
11–16.
Friedman, J.M. (2004). Modern science versus the stigma of obesity. Nat. Med.
10, 563–569.
Fukumura, D., Ushiyama, A., Duda, D.G., Xu, L., Tam, J., Krishna, V., Chatter-
jee, K., Garkavtsev, I., and Jain, R.K. (2003). Paracrine regulation of angiogen-
esis and adipocyte differentiation during in vivo adipogenesis. Circ. Res. 93,
e88–e97.
Ghorbani, M., and Himms-Hagen, J. (1997). Appearance of brown adipocytes
in white adipose tissue during CL 316,243-induced reversal of obesity and dia-
betes in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 21, 465–475.
Gimble, J.M., Katz, A.J., and Bunnell, B.A. (2007). Adipose-derived stem cells
for regenerative medicine. Circ. Res. 100, 1249–1260.
Goodpaster, B.H., Thaete, F.L., Simoneau, J.A., and Kelley, D.E. (1997). Sub-
cutaneous abdominal fat and thigh muscle composition predict insulin sensi-
tivity independently of visceral fat. Diabetes 46, 1579–1585.
Green, H., and Kehinde, O. (1975). An established preadipose cell line and its
differentiation in culture. II. Factors affecting the adipose conversion. Cell 5,
19–27.
Green, H., and Kehinde, O. (1976). Spontaneous heritable changes leading to
increased adipose conversion in 3T3 cells. Cell 7, 105–113.
Green, H., and Meuth, M. (1974). An established pre-adipose cell line and its
differentiation in culture. Cell 3, 127–133.
Greenwood, M.R., and Hirsch, J. (1974). Postnatal development of adipocyte
cellularity in the normal rat. J. Lipid Res. 15, 474–483.
Greenwood, M.R., Cleary, M.P., and Hirsch, J. (1979). Genetic obesity in man
and rodents. Curr. Concepts Nutr. 8, 143–170.
Guilak, F., Lott, K.E., Awad, H.A., Cao, Q., Hicok, K.C., Fermor, B., andGimble,
J.M. (2006). Clonal analysis of the differentiation potential of human adipose-
derived adult stem cells. J. Cell. Physiol. 206, 229–237.
Guo, S.S., Zeller, C., Chumlea, W.C., and Siervogel, R.M. (1999). Aging, body
composition, and lifestyle: the Fels Longitudinal Study. Am. J. Clin. Nutr. 70,
405–411.
Gupta, R.K., Arany, Z., Seale, P., Mepani, R.J., Ye, L., Conroe, H.M., Roby,
Y.A., Kulaga, H., Reed, R.R., and Spiegelman, B.M. (2010). Transcriptional
control of preadipocyte determination by Zfp423. Nature 464, 619–623.
Gupta, R.K., Mepani, R.J., Kleiner, S., Lo, J.C., Khandekar, M.J., Cohen, P.,
Frontini, A., Bhowmick, D.C., Ye, L., Cinti, S., and Spiegelman, B.M. (2012).
Zfp423 expression identifies committed preadipocytes and localizes to adi-
pose endothelial and perivascular cells. Cell Metab. 15, 230–239.
Ha¨ger, A., Sjo¨strm, L., Arvidsson, B., Bjo¨rntorp, P., and Smith, U. (1977). Body
fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism
26, 607–614.Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc. 17
Cell Metabolism
PerspectiveHammar, J.A. (1895). Contribution to our knowledge of adipose tissue. Arch.
Mikrosk. Anat. 45, 512.
Han, J., Lee, J.E., Jin, J., Lim, J.S., Oh, N., Kim, K., Chang, S.I., Shibuya, M.,
Kim, H., and Koh, G.Y. (2011). The spatiotemporal development of adipose tis-
sue. Development 138, 5027–5037.
Hemmeryckx, B., Loeckx, D., Dresselaers, T., Himmelreich, U., Hoylaerts,
M.F., and Lijnen, H.R. (2010). Age-associated adaptations in murine adipose
tissues. Endocr. J. 57, 925–930.
Hevener, A.L., Olefsky, J.M., Reichart, D., Nguyen, M.T., Bandyopadyhay, G.,
Leung, H.Y.,Watt, M.J., Benner, C., Febbraio, M.A., Nguyen, A.K., et al. (2007).
Macrophage PPAR gamma is required for normal skeletal muscle and hepatic
insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin.
Invest. 117, 1658–1669.
Hirsch, J., and Batchelor, B. (1976). Adipose tissue cellularity in human
obesity. Clin. Endocrinol. Metab. 5, 299–311.
Hirsch, J., and Han, P.W. (1969). Cellularity of rat adipose tissue: effects of
growth, starvation, and obesity. J. Lipid Res. 10, 77–82.
Hirsch, J., and Knittle, J.L. (1970). Cellularity of obese and nonobese human
adipose tissue. Fed. Proc. 29, 1516–1521.
Holmes, C., and Stanford, W.L. (2007). Concise review: stem cell antigen-1:
expression, function, and enigma. Stem Cells 25, 1339–1347.
Hong, L., Peptan, I.A., Colpan, A., and Daw, J.L. (2006). Adipose tissue engi-
neering by human adipose-derived stromal cells. Cells Tissues Organs (Print)
183, 133–140.
Hood, R.L., and Allen, C.E. (1973). Cellularity of bovine adipose tissue. J. Lipid
Res. 14, 605–610.
Imrie, D., and Sadler, K.C. (2010). White adipose tissue development in zebra-
fish is regulated by both developmental time and fish size. Dev. Dyn. 239,
3013–3023.
Janke, J., Engeli, S., Gorzelniak, K., Luft, F.C., and Sharma, A.M. (2002).
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via
angiotensin type 1 receptors. Diabetes 51, 1699–1707.
Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A.E., Cushman,
S.W., and Periwal, V. (2009). Hypertrophy and/or Hyperplasia: Dynamics of
Adipose Tissue Growth. PLoS Comput. Biol. 5, e1000324.
Joe, A.W., Yi, L., Even, Y., Vogl, A.W., and Rossi, F.M. (2009). Depot-specific
differences in adipogenic progenitor abundance and proliferative response to
high-fat diet. Stem Cells 27, 2563–2570.
Joe, A.W., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M.A.,
and Rossi, F.M. (2010). Muscle injury activates resident fibro/adipogenic pro-
genitors that facilitate myogenesis. Nat. Cell Biol. 12, 153–163.
Johnson, P.R., and Hirsch, J. (1972). Cellularity of adipose depots in six strains
of genetically obese mice. J. Lipid Res. 13, 2–11.
Johnson, P.R., Zucker, L.M., Cruce, J.A., and Hirsch, J. (1971). Cellularity of
adipose depots in the genetically obese Zucker rat. J. Lipid Res. 12, 706–714.
Kelley, D.E., Thaete, F.L., Troost, F., Huwe, T., and Goodpaster, B.H. (2000).
Subdivisions of subcutaneous abdominal adipose tissue and insulin resis-
tance. Am. J. Physiol. Endocrinol. Metab. 278, E941–E948.
Klyde, B.J., and Hirsch, J. (1979). Increased cellular proliferation in adipose tis-
sue of adult rats fed a high-fat diet. J. Lipid Res. 20, 705–715.
Knittle, J.L. (1978). Adipose tissue development in man. (New York: Plenum
Press).
Knittle, J.L., and Hirsch, J. (1968). Effect of early nutrition on the development
of rat epididymal fat pads: cellularity andmetabolism. J. Clin. Invest. 47, 2091–
2098.
Knittle, J.L., Timmers, K., Ginsberg-Fellner, F., Brown, R.E., and Katz, D.P.
(1979). The growth of adipose tissue in children and adolescents. Cross-
sectional and longitudinal studies of adipose cell number and size. J. Clin.
Invest. 63, 239–246.
Koh, Y.J., Kang, S., Lee, H.J., Choi, T.S., Lee, H.S., Cho, C.H., and Koh, G.Y.
(2007). Bone marrow-derived circulating progenitor cells fail to transdifferenti-18 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.ate into adipocytes in adult adipose tissues in mice. J. Clin. Invest. 117, 3684–
3695.
Kral, J.G. (1976). Surgical reduction of adipose tissue in the male Sprague-
Dawley rat. Am. J. Physiol. 231, 1090–1096.
Lee, Y.K., and Cowan, C.A. (2013). White to brite adipocyte transition and back
again. Nat. Cell Biol. 15, 568–569.
Lee, Y.H., Petkova, A.P., Mottillo, E.P., and Granneman, J.G. (2012). In vivo
identification of bipotential adipocyte progenitors recruited by b3-adrenocep-
tor activation and high-fat feeding. Cell Metab. 15, 480–491.
Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M.,
and Kliewer, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity
ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
J. Biol. Chem. 270, 12953–12956.
Lemonnier, D. (1972). Effect of age, sex, and sites on the cellularity of the
adipose tissue in mice and rats rendered obese by a high-fat diet. J. Clin.
Invest. 51, 2907–2915.
Lemos, D.R., Paylor, B., Chang, C., Sampaio, A., Underhill, T.M., and Rossi,
F.M. (2012). Functionally convergent white adipogenic progenitors of different
lineages participate in a diffused system supporting tissue regeneration. Stem
Cells 30, 1152–1162.
Leonhardt, W., Hanefeld, M., Schneider, H., and Haller, H. (1972). Human
adipocyte volumes: maximum size, and correlation to weight index in maturity
onset-diabetes. Diabetologia 8, 287–291.
Lin, C.S., Xin, Z.C., Deng, C.H., Ning, H., Lin, G., and Lue, T.F. (2010). Defining
adipose tissue-derived stem cells in tissue and in culture. Histol. Histopathol.
25, 807–815.
Majka, S.M., Fox, K.E., Psilas, J.C., Helm, K.M., Childs, C.R., Acosta, A.S.,
Janssen, R.C., Friedman, J.E., Woessner, B.T., Shade, T.R., et al. (2010). De
novo generation of white adipocytes from the myeloid lineage via mesen-
chymal intermediates is age, adipose depot, and gender specific. Proc. Natl.
Acad. Sci. USA 107, 14781–14786.
Majka, S.M., Miller, H.L., Sullivan, T., Erickson, P.F., Kong, R., Weiser-Evans,
M., Nemenoff, R., Moldovan, R., Morandi, S.A., Davis, J.A., and Klemm, D.J.
(2012). Adipose lineage specification of bone marrow-derived myeloid cells.
Adipocyte 1, 215–229.
Manolopoulos, K.N., Karpe, F., and Frayn, K.N. (2010). Gluteofemoral body fat
as a determinant of metabolic health. Int J Obes (Lond) 34, 949–959.
Mao, J., Yang, T., Gu, Z., Heird, W.C., Finegold, M.J., Lee, B., and Wakil, S.J.
(2009). aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes
growth retardation and reduced lipid accumulation in adipose tissues. Proc.
Natl. Acad. Sci. USA 106, 17576–17581.
Mattsson, C., and Olsson, T. (2007). Estrogens and glucocorticoid hormones
in adipose tissue metabolism. Curr. Med. Chem. 14, 2918–2924.
McCollough, A.W. (1944). Evidence of macrophagal origin of adipose cells in
the white rat as shown by studies on starved animals. J. Morphol. 75, 193–201.
Miles, P.D., Barak, Y., He,W., Evans, R.M., and Olefsky, J.M. (2000). Improved
insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J. Clin.
Invest. 105, 287–292.
Miller, R.E., Hackenberg, R., and Gershman, H. (1978). Regulation of gluta-
mine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibu-
tyryl cyclic AMP. Proc. Natl. Acad. Sci. USA 75, 1418–1422.
Miller, W.H., Jr., Faust, I.M., and Hirsch, J. (1984). Demonstration of de novo
production of adipocytes in adult rats by biochemical and radioautographic
techniques. J. Lipid Res. 25, 336–347.
Misra, A., Garg, A., Abate, N., Peshock, R.M., Stray-Gundersen, J., and
Grundy, S.M. (1997). Relationship of anterior and posterior subcutaneous
abdominal fat to insulin sensitivity in nondiabetic men. Obes. Res. 5, 93–99.
Mitchell, J.B., McIntosh, K., Zvonic, S., Garrett, S., Floyd, Z.E., Kloster, A., Di
Halvorsen, Y., Storms, R.W., Goh, B., Kilroy, G., et al. (2006). Immunopheno-
type of human adipose-derived cells: temporal changes in stromal-associated
and stem cell-associated markers. Stem Cells 24, 376–385.
Morikawa, S., Mabuchi, Y., Kubota, Y., Nagai, Y., Niibe, K., Hiratsu, E., Suzuki,
S., Miyauchi-Hara, C., Nagoshi, N., Sunabori, T., et al. (2009). Prospective
Cell Metabolism
Perspectiveidentification, isolation, and systemic transplantation of multipotent mesen-
chymal stem cells in murine bone marrow. J. Exp. Med. 206, 2483–2496.
Mullican, S.E., Tomaru, T., Gaddis, C.A., Peed, L.C., Sundaram, A., and Lazar,
M.A. (2013). A novel adipose-specific gene deletion model demonstrates
potential pitfalls of existing methods. Mol. Endocrinol. 27, 127–134.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593–605.
Napolitano, L. (1963). THE DIFFERENTIATION OF WHITE ADIPOSE CELLS.
AN ELECTRON MICROSCOPE STUDY. J. Cell Biol. 18, 663–679.
Ng, C.W., Poznanski, W.J., Borowiecki, M., and Reimer, G. (1971). Differ-
ences in growth in vitro of adipose cells from normal and obese patients.
Nature 231, 445.
Nicklas, B.J., Cesari, M., Penninx, B.W., Kritchevsky, S.B., Ding, J., Newman,
A., Kitzman, D.W., Kanaya, A.M., Pahor, M., and Harris, T.B. (2006). Abdominal
obesity is an independent risk factor for chronic heart failure in older people.
J. Am. Geriatr. Soc. 54, 413–420.
Nielsen, P.J., Lorenz, B., Mu¨ller, A.M., Wenger, R.H., Brombacher, F., Simon,
M., von der Weid, T., Langhorne, W.J., Mossmann, H., and Ko¨hler, G. (1997).
Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-
deficient mice. Blood 89, 1058–1067.
Ogden, C.L., Carroll, M.D., and Fryar, C.D. (2012). Prevalence of obesity in the
United States, 2009–2010. NCHS data brief, no. 82. (Hyattsville, MD: National
Center for Health Sciences).
Pfaff, F.E., and Austic, R.E. (1976). Influence of diet and development of the
abdominal fat pad in the pullet. J. Nutr. 106, 443–450.
Poissonnet, C.M., Burdi, A.R., and Bookstein, F.L. (1983). Growth and
development of human adipose tissue during early gestation. Early Hum.
Dev. 8, 1–11.
Poissonnet, C.M., Burdi, A.R., and Garn, S.M. (1984). The chronology of adi-
pose tissue appearance and distribution in the human fetus. Early Hum.
Dev. 10, 1–11.
Rivers, L.E., Young, K.M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kes-
saris, N., and Richardson, W.D. (2008). PDGFRA/NG2 glia generate myelinat-
ing oligodendrocytes and piriform projection neurons in adult mice. Nat.
Neurosci. 11, 1392–1401.
Rodbell, M. (1964). METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF
HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J. Biol. Chem.
239, 375–380.
Rodeheffer, M.S., Birsoy, K., and Friedman, J.M. (2008). Identification of white
adipocyte progenitor cells in vivo. Cell 135, 240–249.
Rosen, E.D., and MacDougald, O.A. (2006). Adipocyte differentiation from the
inside out. Nat. Rev. Mol. Cell Biol. 7, 885–896.
Rosenwald, M., Perdikari, A., Ru¨licke, T., and Wolfrum, C. (2013). Bi-direc-
tional interconversion of brite and white adipocytes. Nat. Cell Biol. 15,
659–667.
Rubin, C.S., Hirsch, A., Fung, C., and Rosen, O.M. (1978). Development of hor-
mone receptors and hormonal responsiveness in vitro. Insulin receptors and
insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells.
J. Biol. Chem. 253, 7570–7578.
Rupnick, M.A., Panigrahy, D., Zhang, C.Y., Dallabrida, S.M., Lowell, B.B.,
Langer, R., and Folkman, M.J. (2002). Adipose tissue mass can be regulated
through the vasculature. Proc. Natl. Acad. Sci. USA 99, 10730–10735.
Russell, T.R., and Ho, R. (1976). Conversion of 3T3 fibroblasts into adipose
cells: triggering of differentiation by prostaglandin F2alpha and 1-methyl-3-
isobutyl xanthine. Proc. Natl. Acad. Sci. USA 73, 4516–4520.
Salans, L.B., Knittle, J.L., and Hirsch, J. (1968). The role of adipose cell size
and adipose tissue insulin sensitivity in the carbohydrate intolerance of human
obesity. J. Clin. Invest. 47, 153–165.
Salans, L.B., Cushman, S.W., and Weismann, R.E. (1973). Studies of human
adipose tissue. Adipose cell size and number in nonobese and obese patients.
J. Clin. Invest. 52, 929–941.Sanchez-Gurmaches, J., Hung, C.M., Sparks, C.A., Tang, Y., Li, H., and Guer-
tin, D.A. (2012). PTEN loss in the Myf5 lineage redistributes body fat and
reveals subsets of white adipocytes that arise from Myf5 precursors. Cell
Metab. 16, 348–362.
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scime`, A.,
Devarakonda, S., Conroe, H.M., Erdjument-Bromage, H., et al. (2008).
PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961–967.
Seale, P., Conroe, H.M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J.,
Cohen, P., Cinti, S., and Spiegelman, B.M. (2011). Prdm16 determines the
thermogenic program of subcutaneous white adipose tissue in mice. J. Clin.
Invest. 121, 96–105.
Sengene`s, C., Lolme`de, K., Zakaroff-Girard, A., Busse, R., and Bouloumie´, A.
(2005). Preadipocytes in the human subcutaneous adipose tissue display
distinct features from the adult mesenchymal and hematopoietic stem cells.
J. Cell. Physiol. 205, 114–122.
Sera, Y., LaRue, A.C., Moussa, O., Mehrotra, M., Duncan, J.D., Williams, C.R.,
Nishimoto, E., Schulte, B.A., Watson, P.M., Watson, D.K., and Ogawa, M.
(2009). Hematopoietic stem cell origin of adipocytes. Exp. Hematol. 37,
1108–1120, e1–e4.
Shan, T., Liang, X., Bi, P., Zhang, P., Liu, W., and Kuang, S. (2013). Distinct
populations of adipogenic and myogenic Myf5-lineage progenitors in white
adipose tissues. J. Lipid Res. 54, 2214–2224.
Siegel, M.J., Hildebolt, C.F., Bae, K.T., Hong, C., and White, N.H. (2007). Total
and intraabdominal fat distribution in preadolescents and adolescents: mea-
surement with MR imaging. Radiology 242, 846–856.
Snijder, M.B., Dekker, J.M., Visser, M., Yudkin, J.S., Stehouwer, C.D., Bouter,
L.M., Heine, R.J., Nijpels, G., and Seidell, J.C. (2003). Larger thigh and hip cir-
cumferences are associated with better glucose tolerance: the Hoorn study.
Obes. Res. 11, 104–111.
Soukas, A., Socci, N.D., Saatkamp, B.D., Novelli, S., and Friedman, J.M.
(2001). Distinct transcriptional profiles of adipogenesis in vivo and in vitro.
J. Biol. Chem. 276, 34167–34174.
Spalding, K.L., Arner, E., Westermark, P.O., Bernard, S., Buchholz, B.A., Berg-
mann, O., Blomqvist, L., Hoffstedt, J., Na¨slund, E., Britton, T., et al. (2008).
Dynamics of fat cell turnover in humans. Nature 453, 783–787.
Spiegelman, B.M., and Flier, J.S. (2001). Obesity and the regulation of energy
balance. Cell 104, 531–543.
Stanford, W.L., Haque, S., Alexander, R., Liu, X., Latour, A.M., Snodgrass,
H.R., Koller, B.H., and Flood, P.M. (1997). Altered proliferative response by
T lymphocytes of Ly-6A (Sca-1) null mice. J. Exp. Med. 186, 705–717.
Sternson, S.M., Nicholas Betley, J., and Cao, Z.F. (2013). Neural circuits and
motivational processes for hunger. Curr. Opin. Neurobiol. 23, 353–360.
Stiles, J.W., Francendese, A.A., and Masoro, E.J. (1975). Influence of age on
size and number of fat cells in the epididymal depot. Am. J. Physiol. 229,
1561–1568.
Styner, M., Sen, B., Xie, Z., Case, N., and Rubin, J. (2010). Indomethacin pro-
motes adipogenesis of mesenchymal stem cells through a cyclooxygenase in-
dependent mechanism. J. Cell. Biochem. 111, 1042–1050.
Tang, Q.Q., and Lane, M.D. (2012). Adipogenesis: from stem cell to adipocyte.
Annu. Rev. Biochem. 81, 715–736.
Tang, Q.Q., Otto, T.C., and Lane, M.D. (2003). CCAAT/enhancer-binding pro-
tein beta is required for mitotic clonal expansion during adipogenesis. Proc.
Natl. Acad. Sci. USA 100, 850–855.
Tang, W., Zeve, D., Suh, J.M., Bosnakovski, D., Kyba, M., Hammer, R.E., Tall-
quist, M.D., and Graff, J.M. (2008). White fat progenitor cells reside in the
adipose vasculature. Science 322, 583–586.
Tanko´, L.B., Bagger, Y.Z., Alexandersen, P., Larsen, P.J., and Christiansen, C.
(2003). Peripheral adiposity exhibits an independent dominant antiatherogenic
effect in elderly women. Circulation 107, 1626–1631.
Taylor, S.M., and Jones, P.A. (1979). Multiple new phenotypes induced in
10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17, 771–779.
Tchoukalova, Y.D., Fitch, M., Rogers, P.M., Covington, J.D., Henagan, T.M.,
Ye, J., Hellerstein, M.K., and Ravussin, E. (2012). In vivo adipogenesis in ratsCell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc. 19
Cell Metabolism
Perspectivemeasured by cell kinetics in adipocytes and plastic-adherent stroma-vascular
cells in response to high-fat diet and thiazolidinedione. Diabetes 61, 137–144.
Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M.
(1994). mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Genes Dev. 8, 1224–1234.
Tran, T.T., Yamamoto, Y., Gesta, S., and Kahn, C.R. (2008). Beneficial effects
of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410–420.
Tran, K.V., Gealekman, O., Frontini, A., Zingaretti, M.C., Morroni, M., Gior-
dano, A., Smorlesi, A., Perugini, J., De Matteis, R., Sbarbati, A., et al. (2012).
The vascular endothelium of the adipose tissue gives rise to both white and
brown fat cells. Cell Metab. 15, 222–229.
Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S., and Tsuchida, K. (2010).
Mesenchymal progenitors distinct from satellite cells contribute to ectopic
fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143–152.
Wang, Y., Rimm, E.B., Stampfer, M.J., Willett, W.C., and Hu, F.B. (2005). Com-
parison of abdominal adiposity and overall obesity in predicting risk of type 2
diabetes among men. Am. J. Clin. Nutr. 81, 555–563.
Wang, Q.A., Tao, C., Gupta, R.K., and Scherer, P.E. (2013). Tracking adipo-
genesis during white adipose tissue development, expansion and regenera-
tion. Nat. Med. 19, 1338–1344.
Wassermann, F. (1926). Die Fettorgane des Menchen. Entwicklung, Bau und
systematische Stellung des sogenannten Fettgewebes. Zeit. f. Zellforsch. u.
Mikr. Anat. 3, 325–329.
Wassermann, F. (1927). On the formation of appendices epiploicae in man,
with consideration of the development of the fat organs therein. Ergeb. Anat.
Anz. 63.20 Cell Metabolism 19, January 7, 2014 ª2014 Elsevier Inc.Wassermann, F. (1929). On storage, mobilization, and renewed storage in fat
organs. Ergeb. Anat. Anz. 67.
Wassermann, F. (1965). The development of adipose tissue. In Handbook of
Physiology Section 5: Adipose Tissue, A.E.a.C.G.F. Renold, ed. (Washington,
D.C.: American Physiological Society), pp. 87–100.
WHO. (2013). Obesity and overweight. WHO. (World Health Organization).
Yang, M.U., Presta, E., and Bjo¨rntorp, P. (1990). Refeeding after fasting in rats:
effects of duration of starvation and refeeding on food efficiency in diet-
induced obesity. Am. J. Clin. Nutr. 51, 970–978.
Zheng, B., Cao, B., Li, G., and Huard, J. (2006). Mouse adipose-derived stem
cells undergo multilineage differentiation in vitro but primarily osteogenic and
chondrogenic differentiation in vivo. Tissue Eng. 12, 1891–1901.
Zhu, Y., Qi, C., Korenberg, J.R., Chen, X.N., Noya, D., Rao, M.S., and Reddy,
J.K. (1995). Structural organization of mouse peroxisome proliferator-acti-
vated receptor gamma (mPPAR gamma) gene: alternative promoter use and
different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci.
USA 92, 7921–7925.
Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P.,
Lorenz, H.P., and Hedrick, M.H. (2001). Multilineage cells from human adipose
tissue: implications for cell-based therapies. Tissue Eng. 7, 211–228.
Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H.,
Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. (2002). Human
adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13,
4279–4295.
